In re Viagra (Sildenafil Citrate) Products Liability Litigation

TRANSFER ORDER

Before the Panel:* Plaintiffs in ten actions move under 28 U.S.C. 1407(c) for transfer of the actions listed on Schedule A to the Northern District of California for inclusion in MDL No. 2691. The initial transfer order in MDL No. 2691 centralized actions involving allegations that Viagra, an oral erectile dysfunction (ED) drug in the class of medications known as PDE5 inhibitors,1 causes or increases the risk of developing melanoma. See In re: Viagra (Sildenafil Citrate) Prods. Liab. Litig., 176 F.Supp.3d 1377, 1378 (J.P.M.L. 2016). In the ten actions on the motion, plaintiffs…